(5R,6S)-6-[(1R)-1-hydroxyethyl]-3-[(2-methanimidamidoethyl)sulfanyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

BGC Id:	164228521670
CAS No:	64221-86-9
Synonyms:	n-formimidoylthiena ; imipenam ; lmipenem ; mk-787 ; imipenem ; (5r-(5-alpha,6-alpha(r*)))-nomethyl)amino)ethyl)thio)-7-oxo ; n-formimidoylthienamycin ; tienamycin ; imipenen ; imipemide
Molecular Formula:	C12H17N3O4S
Molecular Weight:	299.35
EINECS:	264-734-5

What other providers are available for CAS 64221-86-9?

Identify

Synonyms:

n-formimidoylthiena ; imipenam ; lmipenem ; mk-787 ; imipenem ; (5r-(5-alpha,6-alpha(r*)))-nomethyl)amino)ethyl)thio)-7-oxo ; n-formimidoylthienamycin ; tienamycin ; imipenen ; imipemide

CAS:

64221-86-9

EINECS:

264-734-5

Molecular Formula:

C12H17N3O4S

MDL:

MFCD09753321

Properties

Molecular Weight:

299.35 g·mol−1

Melting point:

106-111 C

Boiling point:

567.3° C at 760 mmHg (Predicted)

Safety Information

Hazard Symbols: Xi

Europe standard Hazard pictograms, code and definition

Hazard Classes:

Risk Codes:

36/37/38 (R)

Safety Codes:

26-27-36/37/39 (S)

What other providers are available for CAS 64221-86-9?

In addition to the providers presented here for (5R,6S)-6-[(1R)-1-hydroxyethyl]-3-[(2-methanimidamidoethyl)sulfanyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid with the CAS number 64221-86-9, there are other 49 providers with slightly different product names available for this CAS number.

Imipenem

Hangzhou Meite Industry Co., Ltd (Hangzhou Meite Chemical Co., Ltd) | Nantong Xindao Biotech Ltd | Carbone Scientific Co., Ltd. | Leap Chem Co., Ltd +38 additional providers that we know from the past

Imipenem-cilastatin

+2 additional providers that we know from the past

p-Nitrobenzyl-(3R,5R,6S)-6-((R)-1-hydroxyethyl)-1-carba-2-oxopename-3-carboxylate

BuGuCh & Partners +1 additional providers that we know from the past

1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 6-[(1R)-1-hydroxyethyl]-3-[[2-[(iminomethyl)amino]ethyl]thio]-7-oxo-,(5R,6S)-

Hangzhou Zhongqi Chem Co., Ltd +1 additional providers that we know from the past